Sugi Predict

Sugi Predict / Compounds / SCHEMBL332786

SCHEMBL332786

SCHEMBL332786

Cn1nccc1-c1ccc(Sc2cccc(C3(C(N)=O)CCOCC3)c2)c(F)c1

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALOX5 P09917 6/20 0.61
▸ PIK3CD O00329 1/20 0.42
▸ AKT1 P31749 5/20 0.36
▸ AKT2 P31751 3/20 0.33
▸ SGK1 O00141 2/20 0.33
▸ RPS6KB1 P23443 2/20 0.33
▸ PRKCQ Q04759 2/20 0.33
▸ ROCK1 Q13464 2/20 0.33
▸ RPS6KA1 Q15418 2/20 0.33
▸ AKT3 Q9Y243 2/20 0.33
▸ ROCK2 O75116 1/20 0.33
▸ MAPK1 P28482 2/20 0.33
▸ HDAC4 P56524 1/20 0.33
▸ P2RX7 Q99572 1/20 0.33
▸ ABL1 P00519 1/20 0.33
▸ USP30 Q70CQ3 1/20 0.33
▸ PDK1 Q15118 1/20 0.33
▸ PDK2 Q15119 1/20 0.33
▸ PDK3 Q15120 1/20 0.33
▸ PDK4 Q16654 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL332209 0.89 ALOX5 (0.61) ALOX5PIK3CDAKT1P2RX7ABL1
Pf-4191834 SCHEMBL29369341 0.87 ALOX5 (0.81) ALOX5PIK3CDAKT1P2RX7ABL1
Pf-4191834 SCHEMBL332973 0.87 ALOX5 (0.81) ALOX5PIK3CDAKT1P2RX7ABL1
SCHEMBL332424 0.85 ALOX5 (0.62) ALOX5PIK3CDAKT1AKT2HDAC4
SCHEMBL332240 0.83 ALOX5 (0.76) ALOX5PIK3CDAKT1AKT2SGK1
SCHEMBL10193056 0.81 ALOX5 (0.48) ALOX5PIK3CDAKT1P2RX7ABL1
SCHEMBL332843 0.80 ALOX5 (0.52) ALOX5PIK3CD
SCHEMBL332437 0.80 ALOX5 (0.63) ALOX5PIK3CDAKT1
SCHEMBL15803498 0.79 ALOX5 (0.68) ALOX5PIK3CDAKT1P2RX7ABL1
SCHEMBL332613 0.79 ALOX5 (0.62) ALOX5PIK3CDAKT1P2RX7

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8097733-B2 Pyrazole derivatives as 5-LO-inhibitors PFIZER INC. (US) 2012-01-17 — — US disclosed
US-8097733-B2 Pyrazole derivatives as 5-LO-inhibitors PFIZER INC. (US) 2012-01-17 — — US disclosed
US-8097733-B2 Pyrazole derivatives as 5-LO-inhibitors PFIZER INC. (US) 2012-01-17 — — US disclosed
EP-2225229-A1 PYRAZOLE DERIVATIVES AS 5-LO INHIBITORS Pfizer Inc. (US) 2010-09-08 — — EP disclosed
US-20090227634-A1 Pyrazole Derivatives as 5-LO-Inhibitors PFIZER INC. 2009-09-10 — — US disclosed
US-20090227634-A1 Pyrazole Derivatives as 5-LO-Inhibitors PFIZER INC. 2009-09-10 — — US disclosed
US-20090227634-A1 Pyrazole Derivatives as 5-LO-Inhibitors PFIZER INC. 2009-09-10 — — US disclosed
WO-2009069044-A1 PYRAZOLE DERIVATIVES AS 5-LO INHIBITORS PFIZER INC. (US) 2009-06-04 — — WO disclosed
WO-2009069044-A1 PYRAZOLE DERIVATIVES AS 5-LO INHIBITORS PFIZER INC. (US) 2009-06-04 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090227634-A1 Pyrazole Derivatives as 5-LO-Inhibitors ALOX5, ALOX15, CYP3A5 ALOX5 1/4885PIK3CD 1305/4885AKT1 3057/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.